Prostate Cancer Reports
54

Volume 5 Number 8
August 2017



Home > Prostate Cancer Reports > Volume 5, Year 2017 > Number 8, August


CONTENTS



DIAGNOSIS AND EVALUATION
EPIDEMIOLOGY, RISK FACTORS AND PREVENTION
FOLLOW-UP AND QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS AND OUTCOMES
TREATMENT





DIAGNOSIS AND EVALUATION



Afshar-Oromieh A, Holland-Letz T, Giesel FL, Kratochwil C, Mier W, Haufe S, Debus N, Eder M, Eisenhut M, Schäfer M, Neels O, Hohenfellner M, Kopka K, Kauczor HU, Debus J, Haberkorn U.
Erratum to: Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.
Eur J Nucl Med Mol Imaging. 2017 Jun 28. doi: 10.1007/s00259-017-3763-8. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham AP, Oldroyd R, Parker C, Emberton M; PROMIS study group.
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Lancet. 2017 Feb 25;389(10071):815-822. doi: 10.1016/S0140-6736(16)32401-1. Epub 2017 Jan 20.
Source | Abstract | Full text | Similar articles




Maurer T, Murphy DG, Hofman MS, Eiber M.
PSMA-PET for Lymph Node Detection in Recurrent Prostate Cancer: How do we use the Magic Bullet?
Theranostics. 2017 May 15;7(7):2046-2047. doi: 10.7150/thno.20855. eCollection 2017.
Source | Abstract | Full text | Similar articles




Palapattu GS.
Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: Yes.
J Urol. 2017 Jun 16. pii: S0022-5347(17)67196-9. doi: 10.1016/j.juro.2017.05.039. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Petersen LJ, Nielsen JB, Dettmann K, Fisker RV, Haberkorn U, Stenholt L, Zacho HD.
68Ga-PSMA PET/CT for the detection of bone metastasis in recurrent prostate cancer and a PSA level <2 ng/ml: Two case reports and a literature review.
Mol Clin Oncol. 2017 Jul;7(1):67-72. doi: 10.3892/mco.2017.1280. Epub 2017 May 31.
Source | Abstract | Full text | Similar articles




Punnen S, Parekh DJ.
Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: No.
J Urol. 2017 Jun 16. pii: S0022-5347(17)67197-0. doi: 10.1016/j.juro.2017.05.040. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Roach PJ, Francis R, Emmett L, Hsiao E, Kneebone A, Hruby G, Eade T, Nguyen Q, Thompson B, Cusick T, McCarthy M, Tang C, Ho B, Stricker P, Scott A.
The impact of 68Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study.
J Nucl Med. 2017 Jun 23. pii: jnumed.117.197160. doi: 10.2967/jnumed.117.197160. [Epub ahead of print]
Source | Abstract | Full text | Similar articles | Editor's choice




Schiller K, Sauter K, Dewes S, Eiber M, Maurer T, Gschwend J, Combs SE, Habl G.
Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after 68Ga-PSMA-PET imaging.
Eur J Nucl Med Mol Imaging. 2017 Jun 23. doi: 10.1007/s00259-017-3746-9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Taneja SS.
Re: Diagnostic Accuracy of Multi-Parametric MRI and TRUS Biopsy in Prostate Cancer (PROMIS): A Paired Validating Confirmatory Study.
J Urol. 2017 Jul;198(1):101-102. doi: 10.1016/j.juro.2017.04.055. Epub 2017 Apr 12.
Source | Abstract | Full text | Similar articles





EPIDEMIOLOGY, RISK FACTORS AND PREVENTION



Marous M, Huang WY, Rabkin CS, Hayes RB, Alderete JF, Rosner B, Grubb RL 3rd, Winter AC, Sutcliffe S.
Trichomonas vaginalis infection and risk of prostate cancer: associations by disease aggressiveness and race/ethnicity in the PLCO Trial.
Cancer Causes Control. 2017 Aug;28(8):889-898. doi: 10.1007/s10552-017-0919-6. Epub 2017 Jul 1.
Source | Abstract | Full text | Similar articles





FOLLOW-UP AND QUALITY OF LIFE



Wilt TJ, Jones KM, Barry MJ, Andriole GL, Culkin D, Wheeler T, Aronson WJ, Brawer MK.
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer.
N Engl J Med. 2017 Jul 13;377(2):132-142. doi: 10.1056/NEJMoa1615869.
Source | Abstract | Full text | Similar articles





INTEGRATIVE MEDICINE



Demark-Wahnefried W.
Response to: systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortality by Hackshaw-McGeagh and Colleagues.
Cancer Causes Control. 2017 Jun 24. doi: 10.1007/s10552-017-0911-1. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Rivera M, Ramos Y, Rodríguez-Valentín M, López-Acevedo S, Cubano LA, Zou J, Zhang Q, Wang G, Boukli NM.
Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cells.
PLoS One. 2017 Jun 19;12(6):e0179587. doi: 10.1371/journal.pone.0179587. eCollection 2017.
Source | Abstract | Full text | Similar articles





OVERALL MANAGEMENT



Chi K, Saad F.
New research in prostate cancer, ASCO-GU 2017.
Can Urol Assoc J. 2017 Jun;11(6Suppl2):S166-S168. doi: 10.5489/cuaj.4608.
Source | Abstract | Full text | Similar articles




Gillessen S, Attard G, Beer TM, Beltran H, Bossi A, Bristow R, Carver B, Castellano D, Chung BH, Clarke N, Daugaard G, Davis ID, de Bono J, Dos Reis RB, Drake CG, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Higano CS, James N, Kantoff P, Kellokumpu-Lehtinen PL, Khauli RB, Kramer G, Logothetis C, Maluf F, Morgans AK, Morris MJ, Mottet N, Murthy V, Oh W, Ost P, Padhani AR, Parker C, Pritchard CC, Roach M, Rubin MA, Ryan C, Saad F, Sartor O, Scher H, Sella A, Shore N, Smith M, Soule H, Sternberg CN, Suzuki H, Sweeney C, Sydes MR, Tannock I, Tombal B, Valdagni R, Wiegel T, Omlin A.
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.
Eur Urol. 2017 Jun 24. pii: S0302-2838(17)30497-9. doi: 10.1016/j.eururo.2017.06.002. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Litwin MS, Tan HJ.
The Diagnosis and Treatment of Prostate Cancer: A Review.
JAMA. 2017 Jun 27;317(24):2532-2542. doi: 10.1001/jama.2017.7248.
Source | Abstract | Full text | Similar articles | Editor's choice





PROGNOSIS AND OUTCOMES



Cimino S, Reale G, Castelli T, Favilla V, Giardina R, Russo GI, Privitera S, Morgia G.
Comparison between Briganti, Partin and MSKCC tools in predicting positive lymph nodes in prostate cancer: a systematic review and meta-analysis.
Scand J Urol. 2017 Jun 23:1-6. doi: 10.1080/21681805.2017.1332680. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Freiberger C, Berneking V, Vögeli TA, Kirschner-Hermanns R, Eble MJ, Pinkawa M.
Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer - focus on overall survival.
Radiat Oncol. 2017 Jun 14;12(1):98. doi: 10.1186/s13014-017-0837-5.
Source | Abstract | Full text | Similar articles




Gandaglia G, Boorjian SA, Parker WP, Zaffuto E, Fossati N, Bandini M, Dell'Oglio P, Suardi N, Montorsi F, Karnes RJ, Briganti A.
Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis.
Eur Urol. 2017 Jun 13. pii: S0302-2838(17)30496-7. doi: 10.1016/j.eururo.2017.06.001. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kearns JT, Lin DW.
Prediction models for prostate cancer outcomes: what is the state of the art in 2017?
Curr Opin Urol. 2017 Jun 24. doi: 10.1097/MOU.0000000000000423. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Truong M, Rais-Bahrami S, Nix JW, Messing EM, Miyamoto H, Gordetsky JB.
Perineural Invasion by Prostate Cancer on MR/US Fusion Targeted Biopsy is Associated with Extraprostatic Extension and Early Biochemical Recurrence after Radical Prostatectomy.
Hum Pathol. 2017 Jul 10. pii: S0046-8177(17)30239-3. doi: 10.1016/j.humpath.2017.06.017. [Epub ahead of print] Accepted 2017 Jun 29.
Source | Abstract | Full text | Similar articles





TREATMENT



Chin S, Aherne NJ, Last A, Assareh H, Shakespeare TP.
Toxicity after post-prostatectomy image-guided intensity-modulated radiotherapy using Australian guidelines.
J Med Imaging Radiat Oncol. 2017 Jun 17. doi: 10.1111/1754-9485.12632. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




D'Andrea D, Shariat SF.
Re: Radiation with or Without Antiandrogen Therapy in Recurrent Prostate Cancer.
Eur Urol. 2017 Jun 20. pii: S0302-2838(17)30513-4. doi: 10.1016/j.eururo.2017.06.018. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Dal Pra A, Panje C, Zilli T, Arnold W, Brouwer K, Garcia H, Glatzer M, Gomez S, Herrera F, Kaouthar K, Papachristofilou A, Pesce G, Reuter C, Vees H, Zwahlen DR, Engeler D, Putora PM.
Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice.
Strahlenther Onkol. 2017 Jun 27. doi: 10.1007/s00066-017-1172-3. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hervás A, Gómez-Caamaño A, Casaña M, Gómez-Iturriaga A, Pastor J, Jove J, Mengual JL, Gónzalez-San Segundo C, Muñoz J.
Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database.
Clin Transl Oncol. 2017 Jun 30. doi: 10.1007/s12094-017-1709-z. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Fujimura T, Fukuhara H, Taguchi S, Yamada Y, Sugihara T, Nakagawa T, Niimi A, Kume H, Igawa Y, Homma Y.
Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy.
BMC Cancer. 2017 Jun 29;17(1):454. doi: 10.1186/s12885-017-3439-6.
Source | Abstract | Full text | Similar articles




Golbari NM, Katz AE.
Salvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature Review.
Curr Urol Rep. 2017 Aug;18(8):63. doi: 10.1007/s11934-017-0709-4. Online 2017 Jul 7.
Source | Abstract | Full text | Similar articles




Latorzeff I, Sargos P, Loos G, Supiot S, Guerif S, Carrie C.
Delineation of the Prostate Bed: The "Invisible Target" Is Still an Issue?
Front Oncol. 2017 May 31;7:108. doi: 10.3389/fonc.2017.00108. eCollection 2017.
Source | Abstract | Full text | Similar articles




Radwan N, Phillips R, Ross A, Rowe SP, Gorin MA, Antonarakis ES, Deville C, Greco S, Denmeade S, Paller C, Song DY, Diehn M, Wang H, Carducci M, Pienta KJ, Pomper MG, DeWeese TL, Dicker A, Eisenberger M, Tran PT.
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
BMC Cancer. 2017 Jun 29;17(1):453. doi: 10.1186/s12885-017-3455-6.
Source | Abstract | Full text | Similar articles




Taneja SS.
Re: Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
J Urol. 2017 Jul;198(1):100-102. doi: 10.1016/j.juro.2017.04.048. Epub 2017 Apr 12.
Source | Abstract | Full text | Similar articles